Pharma Digest
By Jan Majta
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Jan Majta
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 39
Description
A fast paced, AI-generated podcast on pharma and biotech news.
| Episode | Date |
|---|---|
|
Episode#39 Apr 1st 2026: Lilly's Centessa Bet
|
Apr 01, 2026 |
|
Episode#38 Mar 31st 2026: Basecamp's Trillion-Gene Atlas
|
Mar 31, 2026 |
|
Episode#37 Mar 30th 2026: AstraZeneca's IL‑33 Win
|
Mar 30, 2026 |
|
Episode#36 March 27th 2026: Merck's $20M Quotient Bet
|
Mar 27, 2026 |
|
Episode#35 Mar 26th 2026: Merck's Terns Play
|
Mar 26, 2026 |
|
Episode#34 Mar 20th 2026: Baylor Taps Nautilus Voyager
|
Mar 20, 2026 |
|
Episode#33 Mar 19th 2026: Lilly's triple‑G diabetes readout
|
Mar 19, 2026 |
|
Episode#32 Mar 18th 2026: Pharma Digest: Xaira's X‑Atlas
|
Mar 18, 2026 |
|
Episode#31 Mar 18th 2026: Pfizer’s atirmociclib phase 2 win
|
Mar 18, 2026 |
|
Episode#30 Mar 17th 2026: Roche expands Nvidia tie-up;
|
Mar 18, 2026 |
|
Episode#29 Mar 17th 2026: Structure touts 16% weight loss
|
Mar 18, 2026 |
|
Episode#28 Mar 16th 2026: Stop asking for an AI
|
Mar 16, 2026 |
|
Episode#27 Mar 16th 2026: CytomX surge, Astellas split
|
Mar 16, 2026 |
|
Episode#26 Mar 13th 2026: Waiv spinout, Copilot Health
|
Mar 14, 2026 |
|
Episode#25 Mar 13th 2026: GSK’s RSV label expansion
|
Mar 14, 2026 |
|
Episode#24 Mar 12th 2026: AI, Radiopharmaceuticals, and the Risks
|
Mar 12, 2026 |
|
Episode#23 Mar 12th 2026: Ultragenyx mid‑trial gene‑therapy signal
|
Mar 12, 2026 |
|
Episode#22 Mar 11th 2026: Radial’s $500M Bet
|
Mar 11, 2026 |
|
Episode#21 Mar 11th 2026: Regeneron's obesity readout
|
Mar 11, 2026 |
|
Episode#20 Mar 10th 2026: Smarter Filings, Smarter Factories
|
Mar 10, 2026 |
|
Episode#19 Mar 10th 2026: Vertex races to FDA
|
Mar 10, 2026 |
|
Episode#18 Mar 09th 2026: CVS, Humana & More
|
Mar 09, 2026 |
|
Episode#17 Mar 09th 2026: FDA OK for Tecvayli
|
Mar 09, 2026 |
|
Episode#16 Mar 06th 2026: Future of Health Tech
|
Mar 06, 2026 |
|
Episode#15 Mar 06th 2026: Merck KGaA drops pipeline assets
|
Mar 06, 2026 |
|
Episode#14 Mar 05th 2026: Episode: AI antibiotics
|
Mar 05, 2026 |
|
Episode#13 Mar 05th 2026: UCB enters TCE space
|
Mar 05, 2026 |
|
Episode#12 Mar 04th 2026: FDA grants breakthrough status to chatbot
|
Mar 04, 2026 |
|
Episode#11 Mar 04th 2026: Ascendis, Lynk, and Novo Nordisk
|
Mar 04, 2026 |
|
Episode#10 Mar 03th 2026: Senhwa-CellType Collaboration, Generate's IPO
|
Mar 03, 2026 |
|
Episode#9 Mar 03th 2026: BioNTech's Lean ADC Trial,
|
Mar 03, 2026 |
|
Episode #8 Mar 02th 2026: Pharma Digest: Lilly's Nvidia Supercomputer
|
Mar 02, 2026 |
|
Episode #7 Mar 02th 2026: United Therapeutics' Phase 3 Win
|
Mar 02, 2026 |
|
Episode#6 Feb 27th 2026: AI Expansion & Healthcare Integration
|
Feb 27, 2026 |
|
Episode#5 Feb 27th 2026: Strategic Collaborations & Pipeline Shifts
|
Feb 27, 2026 |
|
Episode#4 Feb 26th 2026
|
Feb 26, 2026 |
|
Episode#3 Feb 25th 2026
|
Feb 26, 2026 |
|
Episode#2 Feb 25th 2026
|
Feb 25, 2026 |
|
Episode#1 Feb 25th 2026
|
Feb 25, 2026 |